Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism

American Journal of Epidemiology

Volumn 162, Issue 10, 2005, Pages 975-982

  Glynn, Robert J ^a,b   Rosner, Bernard ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Arteriosclerosis; Cerebrovascular accident; Coronary disease; Models; Proportional hazards models; Risk factors; Statistical; Survival analysis; Thromboembolism

Indexed keywords

CHOLESTEROL;

CARDIOVASCULAR DISEASE; HEALTH RISK; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; EXERCISE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; RISK ASSESSMENT; RISK FACTOR; STROKE; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY SIZE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; EXERCISE; HUMANS; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; THROMBOEMBOLISM; UNITED STATES; VENOUS THROMBOSIS;

EID: 27744463911     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwi309     Document Type: Article

References (24)

1. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
2. Wolf PA, D'Agostino RB, Belanger AM, et al. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991;3:312-18.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72.
5. Kannel WB, D'Agostino RB, Sullivan L, et al. Concept and usefulness of cardiovascular risk profiles. Am Heart J 2004;148:16-26.
6. Stokes J, Kannel WB, Wolf PA, et al. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987;75(suppl V):V65-73.
7. Glynn RJ, Rosner B. Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol 2004;57:113-22.
8. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
9. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997;277:642-5.
10. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med 2000;132:689-96.
11. Hansson PO, Eriksson H, Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913." Arch Intern Med 1999;159:1886-90.
12. Tsai AW, Cushman M, Rosamond W, et al. Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 2002;162:1182-9.
13. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med. 1989;321:129-35.
14. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
15. Hebert PR, Rich-Edwards JW, Ridker PM, et al. Height and incidence of cardiovascular disease in male physicians. Circulation 1993;88:1437-43.
16. Glynn RJ, L'Italien GJ, Sesso HD, et al. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002;39:105-10.
17. Klag MJ, He J, Mead LA, et al. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol 1993;3:442-7.
18. World Health Organization. Ischemic heart disease registers: report of the Fifth Working Group, including a second revision of the operating protocol. Copenhagen, Denmark, April 26-29, 1971. Copenhagen, Denmark: World Health Organization, Regional Office for Europe, 1971.
19. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993;12:737-51.
20. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
21. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995;51:524-32.
22. Lee EW, Wei LJ, Amato DJ. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP, Goel PK, eds. Survival analysis: state of the art. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1992;237-47.
23. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrics 1980;67:145-53.
24. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.